Big Data: TMI or
Pharmacovigilance Expeditor?
How to Use Big Data Strategies
to Improve Your Safety Processes

A WCG | CenterWatch FREE Webinar
Tuesday, March 20, 2018 · 1:30 p.m. - 2:30 p.m. EDT

Big data. Natural language. Machine learning. Do you know what these buzzwords can mean for your pharmacovigilance program?

Natural language (the ability to speak into a recording machine and have your words transmitted into a database) and machine learning (which takes all kinds of data from multiple sources) — provide information you can use to improve your drug safety program. You can expedite your pharmacovigilance program by utilizing big data techniques to ferret out serious adverse events, determine the causes of those events, make consequential risk management decisions — and comply with specific regulatory safety mandates.

This webinar provides an overview of big data and its implementation that you won’t get from any book. For example, you’ll find out how the use of natural language enables you to take voice messages and recordings from different sources and add substance to your pharmacovigilance program through transcription and data analysis. You’ll discover how machine learning can plough through vast amounts of material to separate out meaningless information from invaluable data on adverse events... And, yes, you can program the machine to spit out the data, both big and small, that directly impact your pharmacovigilance program. This webinar will open your eyes — and your mind — to the present and future of the Digital Age, in which Big Data will play an essential role.

Here’s what you’ll learn during this interactive session:

  • What Big Data is and isn’t, and how you can utilize it to improve your pharmacovigilance program
  • How the use of natural language can expedite the accurate reporting of adverse events
  • How you can train machines to report whether drugs were a determining factor in an adverse event
  • What the future might bring in terms of new techniques for inputting and analyzing safety data

Take advantage of this free, timely presentation to learn the nuances of big data and new analytical tactics to improve your patient safety program. Sign up now.

Who Will Benefit

This session is appropriate for biopharma professionals who are responsible for pharmacovigilance programs, including individuals holding these job titles:

  • Biosafety professional
  • Safety manager
  • Risk manager
  • Regulatory specialist

Sign Up for FREE Below

Meet Your Presenter


Angela Pitwood

Vice President of Pharmacovigilance

Angela Pitwood is responsible for the ongoing development and management of Vigilare International’s pharmacovigilance operations. With more than 25 years of experience in the pharmaceutical industry, Pitwood is a healthcare professional who offers her clients the assurance that their safety and pharmacovigilance programs are being managed by a seasoned pharmacovigilance executive with experience in developing, implementing and leading global safety operations.